CreatorsPublishersAdvertisers
View more in
Business

Repligen Reinforces Proteins Business With $150M Avitide Acquisition Deal

Benzinga
Benzinga
 2021-09-16

Repligen Corporation (NASDAQ: RGEN) has agreed to acquire privately-held Avitide Inc for approximately $150 million in cash and stock. The deal consideration includes $75 million in cash plus $75 million in Repligen common stock in addition to performance-based earnout payments over the next three years. Avitide is a chromatography developer...

www.benzinga.com

Comments / 0

Comments / 0